SFX by Ex Libris Inc.

Title:	Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
Source:	Nature Genetics [1061-4036] Gerlinger, Marco yr:2014

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Gerlinger, M. "Intratumor heterogeneity and branched evolution revealed by multiregion sequencing." The New England journal of medicine 366.10 (2012): 883-892.
description	2.	Peeters, Scott D. "Massively Parallel Tumor Multigene Sequencing to Evaluate Response to Panitumumab in a Randomized Phase 3 Study of Metastatic Colorectal Cancer." Clinical cancer research 19.7 (2013): 1902-1912.
description	3.	Horswell, S. "Cancer heterogeneity and "The Struggle for Existence": Diagnostic and analytical challenges." Cancer letters 340.2 (2012): 220-226.
description	4.	Johnson, R E E. "Eukaryotic polymerases iota and zeta act sequentially to bypass DNA lesions." Nature 406.6799 (2000): 1015-9.
description	5.	Klmel, K F. "Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of Cancer." Melanoma research 9.5 (1999): 511-519.
description	6.	Shi, H. "Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy." Cancer discovery 4.1 (2013): 80-93.
description	7.	Yap, Timothy A. "Intratumor heterogeneity: seeing the wood for the trees." Science translational medicine 4.127 (2012): 127-127.
description	8.	Marusyk, A. "Tumor heterogeneity: Causes and consequences." Biochimica et biophysica acta. Reviews on cancer 1805.1 (2010): 105-117.
description	9.	Navin, N. "Tumour evolution inferred by single-cell sequencing." Nature 472.7341 (2011): 90-4.
description	10.	Kerr, D. "Genetic prognostic and predictive markers in colorectal cancer." Nature Reviews. Cancer 9.7 (2009): 489-99.
description	11.	"Freedom to err: The expanding cellular functions of translesion DNA polymerases." Molecular cell. 83.20: 3608-3621.
description	12.	Martinez, P. "Computational optimisation of targeted DNA sequencing for cancer detection." Scientific Reports 3.1 (2013): 3309-3309.
description	13.	Gerashchenko, T. S. S. "Intratumor heterogeneity: Nature and biological significance." Biochemistry (Moscow) 78.11 (2013): 1201-1215.
description	14.	Kubicka, S. "Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings." Annals of oncology 24.9 (2013): 2342-2349.
description	15.	Fisher, R. "Cancer heterogeneity: Implications for targeted therapeutics." British Journal of Cancer 108.3 (2013): 479-485.
description	16.	Walker, Brian A. "Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma." Blood 120.5 (2012): 1077-1086.
description	17.	Jessri, M. "Adherence to Dietary Recommendations and Risk of Esophageal Squamous Cell Carcinoma: A Case-Control Study in Iran." Annals of Nutrition & Metabolism 59.2-4 (2011): 166-175.
description	18.	Zhang, Y. "Preferential incorporation of G opposite template T by the low-fidelity human DNA polymerase iota." Molecular and cellular biology 20.19 (2000): 7099-108.
description	19.	Hoption Cann, S A A. "Spontaneous regression: a hidden treasure buried in time." Medical hypotheses 58.2 (2002): 115-9.
description	20.	Shrayer, D P. "Immunization of mice with melanoma cells transfected to secrete the superantigen, staphylococcal enterotoxin A." Cancer Immunology, Immunotherapy 46.1 (1998): 7-13.